Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.

Kirkton RD, Santiago-Maysonet M, Lawson JH, Tente WE, Dahl SLM, Niklason LE, Prichard HL.

Sci Transl Med. 2019 Mar 27;11(485). pii: eaau6934. doi: 10.1126/scitranslmed.aau6934.

PMID:
30918113
2.

Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection.

Kirkton RD, Prichard HL, Santiago-Maysonet M, Niklason LE, Lawson JH, Dahl SLM.

J Surg Res. 2018 Jan;221:143-151. doi: 10.1016/j.jss.2017.08.035. Epub 2017 Sep 19.

3.

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.

Lawson JH, Glickman MH, Ilzecki M, Jakimowicz T, Jaroszynski A, Peden EK, Pilgrim AJ, Prichard HL, Guziewicz M, Przywara S, Szmidt J, Turek J, Witkiewicz W, Zapotoczny N, Zubilewicz T, Niklason LE.

Lancet. 2016 May 14;387(10032):2026-34. doi: 10.1016/S0140-6736(16)00557-2.

4.

An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.

Prichard HL, Manson RJ, DiBernardo L, Niklason LE, Lawson JH, Dahl SL.

J Cardiovasc Transl Res. 2011 Oct;4(5):674-82. doi: 10.1007/s12265-011-9306-y. Epub 2011 Jul 12.

5.

Readily available tissue-engineered vascular grafts.

Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE.

Sci Transl Med. 2011 Feb 2;3(68):68ra9. doi: 10.1126/scitranslmed.3001426.

6.

Bioluminescence imaging of glucose in tissue surrounding polyurethane and glucose sensor implants.

Prichard HL, Schroeder T, Reichert WM, Klitzman B.

J Diabetes Sci Technol. 2010 Sep 1;4(5):1055-62.

7.

IFATS collection: Adipose-derived stromal cells improve the foreign body response.

Prichard HL, Reichert W, Klitzman B.

Stem Cells. 2008 Oct;26(10):2691-5. doi: 10.1634/stemcells.2008-0140. Epub 2008 Apr 24.

8.

Reduced foreign body response at nitric oxide-releasing subcutaneous implants.

Hetrick EM, Prichard HL, Klitzman B, Schoenfisch MH.

Biomaterials. 2007 Nov;28(31):4571-80. Epub 2007 Aug 2.

9.

Effects of glutamine, glucose, and oxygen concentration on the metabolism and proliferation of rabbit adipose-derived stem cells.

Follmar KE, Decroos FC, Prichard HL, Wang HT, Erdmann D, Olbrich KC.

Tissue Eng. 2006 Dec;12(12):3525-33.

PMID:
17518688
10.

Combined bone allograft and adipose-derived stem cell autograft in a rabbit model.

Follmar KE, Prichard HL, DeCroos FC, Wang HT, Levin LS, Klitzman B, Olbrich KC, Erdmann D.

Ann Plast Surg. 2007 May;58(5):561-5.

PMID:
17452844
11.

Adult adipose-derived stem cell attachment to biomaterials.

Prichard HL, Reichert WM, Klitzman B.

Biomaterials. 2007 Feb;28(6):936-46. Epub 2006 Oct 30.

12.

Inhibition of implant-associated infections via nitric oxide release.

Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH.

Biomaterials. 2005 Dec;26(34):6984-90.

PMID:
15978663
13.

An investigation of radioactive yttrium (90Y) for the treatment of chronic knee effusions.

Prichard HL, Bridgman JF, Bleehen NM.

Br J Radiol. 1970 Jul;43(511):466-70. No abstract available.

PMID:
4317014

Supplemental Content

Loading ...
Support Center